Utilization of third-party in vitro fertilization in the United States

Background The use of in vitro fertilization that includes third-party in vitro fertilization is increasing. However, the relative contribution of third-party in vitro fertilization that includes the use of donor oocytes, sperm, or embryo and a gestational carrier to the birth cohort after in vitro...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2017-03, Vol.216 (3), p.266.e1-266.e10
Main Authors: Kushnir, Vitaly A., MD, Darmon, Sarah K., PhD, Shapiro, Alice J., MD, Albertini, David F., PhD, Barad, David H., MD, Gleicher, Norbert, MD
Format: Article
Language:English
Subjects:
Adult
assisted reproductive technology
Birth Rate
donor
embryo
Female
Fertilization in Vitro - statistics & numerical data
gestational carrier
Humans
in vitro fertilization
Obstetrics and Gynecology
oocyte
Oocyte Donation - statistics & numerical data
Retrospective Studies
sperm
third-party reproduction
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The use of in vitro fertilization that includes third-party in vitro fertilization is increasing. However, the relative contribution of third-party in vitro fertilization that includes the use of donor oocytes, sperm, or embryo and a gestational carrier to the birth cohort after in vitro fertilization is unknown. Objective The purpose of this study was to examine the contribution of third-party in vitro fertilization to the in vitro fertilization birth cohort over the past decade. Study Design This retrospective analysis investigated 1,349,874 in vitro fertilization cycles that resulted in 421,525 live births and 549,367 liveborn infants in the United States from 2004–2013. Cycles were self-reported by fertility centers to a national registry: Society for Assisted Reproductive Technologies Clinic Outcome Reporting System. Results Third-party in vitro fertilization accounted for 217,030 (16.1%) of all in vitro fertilization cycles, 86,063 (20.4%) of all live births, and 115,024 (20.9%) of all liveborn infants. Overall, 39.7% of third-party in vitro fertilization cycles resulted in a live birth, compared with 29.6% of autologous in vitro fertilization cycles. Use of third-party in vitro fertilization increased with maternal age and accounted for 42.2% of all in vitro fertilization cycles and 75.3% of all liveborn infants among women >40 years old. Oocyte donation was the most common third-party in vitro fertilization technique, followed by sperm donation. Over the study period, annual cycle volume and live birth rates gradually increased for both autologous in vitro fertilization and third-party in vitro fertilization ( P 20% of the total in vitro fertilization birth cohort. In women who are >40 years old, third-party in vitro fertilization has become the dominant treatment.
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2016.11.1022